학술논문
CRISPR/Cas9-mediated glycolate oxidase disruption is an efficacious and safe treatment for primary hyperoxaluria type I
Document Type
Journal
Author
Zabaleta, Nerea; Barberia, Miren; Martin-Higueras, Cristina; Zapata-Linares, Natalia; Betancor, Isabel; Rodriguez, Saray; Martinez-Turrillas, Rebeca; Torella, Laura; Vales, Africa; Olague, Cristina; Vilas-Zornoza, Amaia; Castro-Labrador, Laura; Lara-Astiaso, David; Prosper, Felipe; Salido, Eduardo; Gonzalez-Aseguinolaza, Gloria; Rodriguez-Madoz, Juan R.
Source
Subject
Language
English
ISSN
20411723